Get the Stockscreener App
0.702
1.82%
-0.013
After Hours:
.66
-0.042
-5.98%
Xtant Medical Holdings Inc Stock (XTNT) Forecast
The Xtant Medical Holdings Inc (XTNT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.0844, representing a +54.47% increase from the current price of $0.702. The highest analyst price target is $1.0903, and the lowest is $1.0785.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month XTNT Price Target
Average 2.5308
(+260.51% Upside)
Is Xtant Medical Holdings Inc (XTNT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 73.24 | Sell |
| STOCH(9,6) | 80.28 | Sell |
| STOCHRSI(14) | 89.20 | Sell |
| MACD(12,26) | 0.0559 | Buy |
| ADX(14) | 21.02 | Neutral |
| William %R | -13.22 | Sell |
| CCI(14) | 125.17 | Buy |
Buy: 2
Sell: 4
Neutral: 1
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.6017
Buy
|
0.6199
Buy
|
| MA20 |
0.5441
Buy
|
0.5674
Buy
|
| MA50 |
0.4927
Buy
|
0.5209
Buy
|
| MA100 |
0.5118
Buy
|
0.5163
Buy
|
| MA200 |
0.5298
Buy
|
0.576
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, XTNT could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 4 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on XTNT, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 73.24 indicates that XTNT is overbought. This suggests that XTNT price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 80.28 indicates that XTNT is oversold. This means that XTNT price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 89.2 indicates that XTNT is oversold. This suggests that XTNT price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.02 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 125.17 indicates that XTNT is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term XTNT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Xtant Medical Holdings Inc financial reports and earnings history, Xtant Medical Holdings Inc (XTNT) stock could reach $1.1078 by 2030, $2.1579 by 2040 and $5.6371 by 2050. See the projected annual prices until 2050 of the Xtant Medical Holdings Inc stock below:
- Xtant Medical Holdings Inc (XTNT) is expected to reach an average price of $0.2281 in 2035, with a high prediction of $0.3688 and a low estimate of $0.3581. This indicates an $-67.51% rise from the last recorded price of $0.702.
- Xtant Medical Holdings Inc (XTNT) stock is projected to chart a bullish course in 2040, with an average price target of $2.1617, representing an $207.93% surge from its current level. The forecast ranges from a conservative $2.1816 to a sky-high $2.1579.
- Our analysts predict Xtant Medical Holdings Inc (XTNT) to jump 423.68% by 2045, soaring from $3.7313 to an average price of $3.6763, potentially reaching $3.7665. While $3.7313 is the low estimate, the potential upside is significant.
- Xtant Medical Holdings Inc (XTNT) stock is expected to climb by 2050, reaching an average of $5.6771, a $708.70% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.6371 and $5.618, respectively, highlighting the market's uncertainty.
Xtant Medical Holdings Inc Stock (XTNT) Year by Year Forecast
Xtant Medical Holdings Inc Stock (XTNT) Price Forecast for 2025
Xtant Medical Holdings Inc Stock (XTNT) is expected to reach an average price of $1.0136 in 2025, with a high prediction of $1.6966 and a low estimate of $0.3305. This indicates an +44.38% rise from the last recorded price of $0.702.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $1.1585 | $1.0785 | $1.0903 | +65.02% |
| July, 2025 | $0.683 | $0.6383 | $1.6966 | -2.71% |
| August, 2025 | $0.8127 | $0.8276 | $0.7628 | +15.77% |
| September, 2025 | $0.6322 | $0.7322 | $0.6073 | -9.94% |
| October, 2025 | $0.9193 | $0.6465 | $1.1329 | +30.95% |
| November, 2025 | $0.8727 | $0.8666 | $0.8475 | +24.32% |
| December, 2025 | $0.5109 | $0.3411 | $0.8087 | -27.22% |
Xtant Medical Holdings Inc Stock (XTNT) Price Forecast for 2026
The predicted value for Xtant Medical Holdings Inc (XTNT) in 2026 is set at an average of $2.5215. Estimates vary from a peak of $5.0008 to a trough of $0.0423, indicating an +259.19% surge from the present price of $0.702.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.4106 | $0.4456 | $0.4258 | -41.52% |
| February, 2026 | $0.4802 | $0.4253 | $0.3955 | -31.60% |
| March, 2026 | $0.3498 | $0.3898 | $0.3851 | -50.17% |
| April, 2026 | $0.5357 | $0.0716 | $0.7257 | -23.69% |
| May, 2026 | $1.396 | $0.0608 | $5.0008 | +98.87% |
| June, 2026 | $0.6864 | $0.6062 | $2.0411 | -2.22% |
| July, 2026 | $0.0781 | $0.0868 | $1.7115 | -88.87% |
| August, 2026 | $0.2823 | $0.073 | $0.3423 | -59.79% |
| September, 2026 | $0.2677 | $0.0423 | $0.4851 | -61.86% |
| October, 2026 | $0.1319 | $0.2071 | $0.9128 | -81.21% |
| November, 2026 | $0.1715 | $0.1768 | $0.1617 | -75.57% |
| December, 2026 | $0.296 | $0.2064 | $0.216 | -57.83% |
Xtant Medical Holdings Inc Stock (XTNT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Xtant Medical Holdings Inc (XTNT) is $0.4824, with a high forecast of $0.7142 and a low forecast of $0.2506. This indicates an -31.29% decrease from the last price of $0.702.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.2057 | $0.3009 | $0.2609 | -70.70% |
| February, 2027 | $0.4753 | $0.2506 | $0.2653 | -32.29% |
| March, 2027 | $0.6097 | $0.6407 | $0.5707 | -13.14% |
| April, 2027 | $0.6714 | $0.6846 | $0.6651 | -4.35% |
| May, 2027 | $0.6691 | $0.7144 | $0.7142 | -4.69% |
| June, 2027 | $0.4336 | $0.5236 | $0.624 | -38.23% |
| July, 2027 | $0.5732 | $0.6231 | $0.5834 | -18.34% |
| August, 2027 | $0.5829 | $0.5681 | $0.5369 | -16.97% |
| September, 2027 | $0.6824 | $0.6278 | $0.6425 | -2.79% |
| October, 2027 | $0.697 | $0.6472 | $0.6181 | -0.71% |
| November, 2027 | $0.6745 | $0.6966 | $0.6617 | -3.91% |
| December, 2027 | $0.6274 | $0.6483 | $0.6264 | -10.63% |
Xtant Medical Holdings Inc Stock (XTNT) Price Forecast for 2028
In 2028, Xtant Medical Holdings Inc (XTNT) is projected to reach an average price of $0.3276, with a high projection of $0.5972 and a low estimate of $0.0581. This indicates an -53.33% fall from the last price of $0.702.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.5408 | $0.6308 | $0.5972 | -22.96% |
| February, 2028 | $0.3806 | $0.499 | $0.45 | -45.78% |
| March, 2028 | $0.4449 | $0.394 | $0.4052 | -36.62% |
| April, 2028 | $0.3702 | $0.4398 | $0.3898 | -47.27% |
| May, 2028 | $0.3728 | $0.3956 | $0.4303 | -46.90% |
| June, 2028 | $0.406 | $0.4186 | $0.364 | -42.16% |
| July, 2028 | $0.2211 | $0.319 | $0.2885 | -68.50% |
| August, 2028 | $0.2278 | $0.0581 | $0.2371 | -67.55% |
| September, 2028 | $0.3025 | $0.2926 | $0.2729 | -56.91% |
| October, 2028 | $0.2971 | $0.322 | $0.2774 | -57.67% |
| November, 2028 | $0.2417 | $0.2917 | $0.2506 | -65.58% |
| December, 2028 | $0.0536 | $0.1858 | $0.1917 | -92.36% |
Xtant Medical Holdings Inc Stock (XTNT) Price Forecast for 2029
The 2029 price forecast for Xtant Medical Holdings Inc Stock (XTNT) is $0.5264 on average, with a high prediction of $1.028 and a low estimate of $0.0248. This represents an -25.01% decrease from the previous price of $0.702.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0751 | $0.0248 | $0.1339 | -89.30% |
| February, 2029 | $0.3396 | $0.1343 | $0.5394 | -51.63% |
| March, 2029 | $0.4399 | $0.2999 | $0.5648 | -37.33% |
| April, 2029 | $0.2903 | $0.2001 | $0.505 | -58.64% |
| May, 2029 | $0.4058 | $0.1901 | $0.5557 | -42.20% |
| June, 2029 | $0.5562 | $0.3659 | $0.7011 | -20.77% |
| July, 2029 | $0.4065 | $0.3214 | $0.7113 | -42.09% |
| August, 2029 | $0.222 | $0.1968 | $0.5916 | -68.38% |
| September, 2029 | $0.3624 | $0.2172 | $0.4121 | -48.38% |
| October, 2029 | $0.3779 | $0.3214 | $0.6274 | -46.17% |
| November, 2029 | $0.1982 | $0.1282 | $0.5929 | -71.76% |
| December, 2029 | $1.248 | $0.1723 | $1.028 | +77.78% |
Xtant Medical Holdings Inc Stock (XTNT) Price Forecast for 2030
Xtant Medical Holdings Inc Stock (XTNT) is expected to reach an average price of $1.9915 in 2030, with a high forecast of $2.9955 and a low forecast of $0.9874. This signifies an +183.69% surge from the last price of $0.702.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.2221 | $0.9874 | $1.1078 | +74.08% |
| February, 2030 | $1.0763 | $1.2569 | $1.1269 | +53.32% |
| March, 2030 | $1.1607 | $1.2856 | $1.1056 | +65.34% |
| April, 2030 | $1.4948 | $1.305 | $1.0652 | +112.94% |
| May, 2030 | $1.219 | $1.3439 | $1.4142 | +73.64% |
| June, 2030 | $1.6589 | $1.2237 | $1.4893 | +136.31% |
| July, 2030 | $2.0822 | $1.7112 | $1.6854 | +196.61% |
| August, 2030 | $2.2614 | $2.2218 | $2.1418 | +222.14% |
| September, 2030 | $2.2207 | $2.2511 | $2.2259 | +216.34% |
| October, 2030 | $2.4497 | $2.3603 | $2.3133 | +248.97% |
| November, 2030 | $2.929 | $2.5892 | $2.5572 | +317.23% |
| December, 2030 | $3.0382 | $3.054 | $2.9955 | +332.80% |
0.50%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):